FAIR Labels Act of 2026
- Bill Number
- H.R. 8596
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Policy Area
- Agriculture and Food
- Status
- Introduced
- Latest Action
- 2026-04-30: Referred to the Committee on Agriculture, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2026-06-24T08:08:00Z
AI-Generated Summary
Purpose
The FAIR Labels Act of 2026 (H.R. 8596) aims to help consumers distinguish between traditional meat and poultry products (from live animals) and newer alternatives like cell-cultivated protein products (lab-grown from animal cells outside the body) and plant-based alternative protein products (plant-derived foods mimicking meat). It does this by requiring clear labeling and shifting regulatory oversight.
Key Provisions
- Revised Agreement Between Agencies: Within 90 days, the Secretary of Agriculture (USDA) and Secretary of Health and Human Services (HHS, overseeing FDA) must update their 2019 Memorandum of Understanding (MOU). USDA will enforce the bill's changes for cell-cultivated products; FDA will handle early stages like cell collection, banking, culturing, safety checks, and inspections.
- Definitions Added:
- Cell-cultivated protein product: Food made from animal cell cultures or DNA, grown outside a live animal (applies to meat under Federal Meat Inspection Act (FMIA) and poultry under Poultry Products Inspection Act (PPIA)).
- Plant-based alternative protein product: Plant-based food mimicking the look, taste, and texture of meat or poultry (under Federal Food, Drug, and Cosmetic Act (FD&C Act)).
- Labeling Requirements (to Prevent Misbranding):
- Cell-cultivated meat/poultry must prominently say "cell-cultivated" next to the product name, state it's not derived from meat/poultry, and disclaim it contains no naturally produced meat from live animals.
- Plant-based alternatives must say "plant-based alternative protein product" next to the name and disclaim no meat/poultry from live animals.
- Full Regulatory Coverage: FMIA and PPIA inspection rules now fully apply to cell-cultivated products, just like traditional meat/poultry.
- Standards Development: Within 180 days, USDA (with HHS input) must create uniform identity standards for these products.
Significant Changes to Existing Law
- Expands USDA Authority: Cell-cultivated meat/poultry now falls under USDA's meat/poultry inspection laws (previously more FDA-led), overriding prior exemptions.
- New Misbranding Rules: Adds specific labeling mandates not previously required, making it illegal to sell without them.
- Clarifies Plant-Based Oversight: Introduces definitions and labels under FD&C Act, ensuring plant alternatives aren't mistaken for animal products.
- Shifts MOU Roles: FDA focuses on pre-harvest cell processes; USDA handles post-production labeling and inspection.
Potential Impacts
- Government Agencies: USDA gains expanded inspection duties and enforcement power; FDA/HHS narrows to upstream safety (e.g., cell tech), potentially streamlining roles but increasing coordination needs.
- Citizens/Consumers: Clearer labels promote informed choices, reducing confusion between traditional and alternative proteins; may affect purchasing habits.
- Industry: Traditional meat producers get protection from "imitation" claims; lab-grown and plant-based makers face stricter labeling, possibly raising costs but ensuring market transparency.
- No Direct International Impact: Focuses on U.S. food labeling and inspection.
Main Stakeholders Affected
- Consumers: Benefit from transparent labeling.
- Traditional Meat/Poultry Producers and Farmers: Protected from competition via distinct labeling.
- Cell-Cultivated Protein Companies: Must comply with USDA inspections and labels, shifting from FDA primacy.
- Plant-Based Food Manufacturers: New labeling under FDA rules.
- USDA and FDA/HHS: Changed oversight responsibilities and workload.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens enforcement against misleading labels under existing food safety laws (FMIA, PPIA, FD&C Act); creates enforceable standards to avoid lawsuits over product imitation.
- Constitutional: No major issues; aligns with Congress's commerce clause authority over food labeling and safety.
- Political: Addresses debates over "fake meat" by favoring transparency for traditional agriculture; bipartisan sponsors signal industry support amid growing alternative protein markets.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (17)
Rep. Flood, Mike [R-NE-1], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Pfluger, August [R-TX-11], Rep. Simpson, Michael K. [R-ID-2], Rep. Smith, Jason [R-MO-8], Rep. Jackson, Ronny [R-TX-13], Rep. Wied, Tony [R-WI-8], Rep. Bacon, Don [R-NE-2], Rep. Mann, Tracey [R-KS-1], Rep. McGuire, John J. [R-VA-5], Rep. Fulcher, Russ [R-ID-1], Rep. Evans, Gabe [R-CO-8], Rep. Boebert, Lauren [R-CO-4], Rep. Gosar, Paul A. [R-AZ-9], Rep. Moore, Barry [R-AL-1], Rep. Moolenaar, John R. [R-MI-2], Rep. Soto, Darren [D-FL-9]
Recent Actions
- 2026-04-30: Referred to the Committee on Agriculture, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2026-04-30: Referred to the Committee on Agriculture, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2026-04-30: Introduced in House
- 2026-04-30: Introduced in House
Bill Versions
- Fair and Accurate Ingredient Representation on Labels Act of 2026 — issued 2026-04-30 — PDF (9 pages)